Literature DB >> 27270164

MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis.

Ming Zhao1, Liang Liang1, Liwei Ji1, Di Chen1, Yatong Zhang1, Yuanchao Zhu1, Alessia Ongaro2.   

Abstract

BACKGROUND: MTHFR gene polymorphisms has been shown to be associated with methotrexate (MTX) toxicity in adult hematological malignancies; however, the results remain inconclusive. MATERIALS &
METHODS: To examine the role of common MTHFR variants in MTX toxicity prediction, we performed a meta-analysis via identifying relevant studies for quantitative data pooling.
RESULTS: Our results showed a significant association between MTHFR C677T polymorphism and increased risk of MTX-induced all-grade (grade 1-4) and severe (grade 3-4) hepatic and gastrointestinal toxicities in Caucasian independent of MTX dosage. MTHFR 677T allele increased risk of severe mucositis and all-grade hematological toxicity. MTHFR A1298C polymorphism was not significantly associated with hepatic and hematological toxicity, whereas perhaps having a protective effect on mucositis and gastrointestinal toxicity.
CONCLUSION: MTHFR C677T polymorphism may be a good predictor for MTX toxicity in adult hematological malignancies.

Entities:  

Keywords:  MTHFR; adult; hematological malignancy; polymorphism; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27270164     DOI: 10.2217/pgs-2016-0004

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  6 in total

1.  Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis.

Authors:  C Zhu; Y W Liu; S Z Wang; X L Li; X L Nie; X T Yu; L B Zhao; X L Wang
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

2.  Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.

Authors:  Mohammad Ali Esmaili; Ahmad Kazemi; Mohammad Faranoush; Hakan Mellstedt; Farhad Zaker; Majid Safa; Narjes Mehrvar; Mohammad Reza Rezvany
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

3.  High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia.

Authors:  Wasil Jastaniah; Naglla Elimam; Khalid Abdalla; Aeshah A AlAzmi; Mohammed Aseeri; Sami Felimban
Journal:  Leuk Res Rep       Date:  2018-10-09

4.  Effects of Methylene Tetrahydro Folate Reductase Gene Polymorphisms on Methotrexate Toxicity in Egyptian Pediatric Acute Lymphocytic Leukaemia Patients.

Authors:  Gomaa Mostafa-Hedeab; Yasser Elborai; Gamal Thabet Ali Ebid
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

5.  MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment.

Authors:  Wenchao Zhang; Zhongyue Liu; Zhimin Yang; Chengyao Feng; Xiaowen Zhou; Chao Tu; Zhihong Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

6.  Photobiomodulation Treatment in Chemotherapy-Induced Oral Mucositis in Young Haematological Patients-A Pilot Study.

Authors:  Paula Fiwek; Katarzyna Emerich; Ninela Irga-Jaworska; Dagmara Pomiecko
Journal:  Medicina (Kaunas)       Date:  2022-07-29       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.